Clinical trial
Multicentre Clinical Study to Assess the Diagnostic Accuracy of the Bioneer Q-RFIA PCR Kit on IRON qPCR for the Detection of MTB and Resistance to Rifampicin, Isoniazid, Fluoroquinolones and Aminoglycosides.
NCT05117788 is registered in ClinicalTrials.gov with Foundation for Innovative New Diagnostics, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicentre Clinical Study to Assess the Diagnostic Accuracy of the Bioneer Q-RFIA PCR Kit on IRON qPCR for the Detection of MTB and Resistance to Rifampicin, Isoniazid, Fluoroquinolones and Aminoglycosides.
- Lead sponsor
- Foundation for Innovative New Diagnostics, Switzerland
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 30, 2026
- Completion date
- June 30, 2027
- Enrollment
- 2,350 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.